| Product NDC: | 0555-9013 | 
| Proprietary Name: | Lessina | 
| Non Proprietary Name: | levonorgestrel and ethinyl estradiol | 
| Active Ingredient(s): | .02; .1 mg/1; mg/1 & nbsp; levonorgestrel and ethinyl estradiol | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0555-9013 | 
| Labeler Name: | Barr Laboratories Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075803 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20020422 | 
| Package NDC: | 0555-9013-57 | 
| Package Description: | 6 POUCH in 1 CARTON (0555-9013-57) > 1 BLISTER PACK in 1 POUCH > 21 TABLET in 1 BLISTER PACK | 
| NDC Code | 0555-9013-57 | 
| Proprietary Name | Lessina | 
| Package Description | 6 POUCH in 1 CARTON (0555-9013-57) > 1 BLISTER PACK in 1 POUCH > 21 TABLET in 1 BLISTER PACK | 
| Product NDC | 0555-9013 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | levonorgestrel and ethinyl estradiol | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20020422 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Barr Laboratories Inc. | 
| Substance Name | ETHINYL ESTRADIOL; LEVONORGESTREL | 
| Strength Number | .02; .1 | 
| Strength Unit | mg/1; mg/1 | 
| Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |